Drug distributor Cardinal Health on Thursday raised its fiscal 2025 adjusted profit forecast as strong demand for costly specialty medicines and branded drugs drove sales at its pharmaceuticals unit.

Cardinal Health's pharmaceutical and specialty solutions segment profit increased 7% to $531 million in the second quarter.

Cardinal Health reported an increase in revenue for two of its segments, while the departure of Optimum impacted its Pharmaceuticals segment.

Cardinal Health has reported second quarter revenue for its “other” businesses, which includes at-Home Solutions, increased 13% to $1.3 billion.

Cardinal Health said its contracts with the pharmacy benefits provider of UnitedHealth Group, OptumRX, won't be renewed, and shares fell in intraday trading Monday. The health insurer noted that ...

Cardinal Health, Inc. operates as a healthcare services ... providers for specialty pharmaceutical products; offers pharmacy management services to hospitals; operates pharmacies, including ...

Cardinal expects full-year earnings to be $7.85 to $8 per share. Cardinal shares have climbed 8% since the beginning of the year, while the S&P's 500 index has climbed 27%. The stock has risen 20% in ...

Cardinal Health announced construction is underway on a new distribution center in Fort Worth, Texas, which will support its at-Home Solutions business, a medical supplies provider that serves more ...

The National Community Pharmacists Association’s Innovation Center has formed the Independent Community Pharmacy Consortium for Government Engagement, bringing together pharmacy services ...

In this article, we are going to take a look at where Cardinal Health, Inc. (NYSE:CAH) stands against the other stocks. In one of his latest appearances on CNBC's Squawk on the Street, Jim Cramer ...